Value Research Rating

3 star

Quality Score fund-quick-summary-circle

Quality Score0/0

Growth Score fund-quick-summary-circle

Growth Score0/0

Valuation Score fund-quick-summary-circle

Valuation Score0/0

Momentum Score fund-quick-summary-circle

Momentum Score0/0

Laurus Labs Ltd. Share Price

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range
Low: 531.55 High: 604.00
52 Week Range
Low: 373.10 High: 646.20
Liquidityliquidity High
Low Moderate High

Fundamentals

  • Market capMarket cap information

    ₹29,473 Cr

  • P/E RatioP/E Ratio information

    147.17

  • P/B RatioP/B Ratio information

    6.98

  • Industry P/EIndustry P/E information

    37.17

  • Debt to EquityDebt to Equity information

    0.61

  • ROEROE information

    4.15 %

  • ROCEROCE information

    6.64 %

  • Div. YieldDiv. Yield information

    0.15 %

  • Book ValueBook Value information

    78.34

  • EPSEPS information

    3.71

10 Years Aggregate

CFO

₹4,740.52 Cr

EBITDA

₹7,641.62 Cr

Net Profit

₹3,691.33 Cr

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Laurus Labs
-9.37 -2.30 14.59 39.19 -0.23 43.99 --
BSE Healthcare
-11.69 -6.28 -6.00 12.99 17.86 22.52 9.66
BSE Mid Cap
-14.35 -6.28 -9.92 2.49 17.89 20.27 13.97
As on 14-Feb-2025
2024
2023
2022
2021
2020
2019
2018
Laurus Labs
39.18 14.64 -30.37 52.49 379.50 -6.06 -29.66
BSE Mid Cap
25.84 45.53 1.38 39.18 19.87 -3.05 -13.31
BSE Healthcare
43.09 36.97 -12.10 20.87 61.45 -3.55 -5.89

Essential Checks View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials Detailed View

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios view all

loading...

loading...

loading...

3Y Avg -- 5Y Avg -- TTM --

loading...
P/E Ratio

--

--Min --Median --Max

loading...
P/B Ratio

--

--Min --Median --Max

loading...
Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peer view all

Company
Price (₹) Market Cap (₹ Cr) P/E Ratio ROE
1,323.05 37,286.93 -- -15.04
184.90 24,499.83 629.82 0.67
1,089.65 27,701.76 99.21 13.86
690.35 27,803.23 55.44 11.04

Shareholding Pattern Detailed Holdings

loading...
BLAHBLAH

News & Analysis All News

About The Company

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV),...  antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.  Read more

  • Incorporated

    2005

  • Chairman

    Ravindranath Kancherla

  • Managing Director

    --

  • Headquarters

    Vishakhapatnam, Andhra Pradesh

  • Website

    www.lauruslabs.com

Edit peer-selector-edit
loading...
loading...
loading...
loading...

FAQs for Laurus Labs Ltd.

The total asset value of Laurus Labs Ltd stood at ₹ 8,729 Cr as on 31-Dec-24

The share price of Laurus Labs Ltd is ₹546.20 (NSE) and ₹546.55 (BSE) as of 14-Feb-2025 IST. Laurus Labs Ltd has given a return of -0.23% in the last 3 years.

Laurus Labs Ltd has a market capitalisation of ₹ 29,473 Cr as on 14-Feb-2025. As per Value Research classification, it is a Mid Cap company.

The P/B ratio of Laurus Labs Ltd is 6.98 times as on 14-Feb-2025, a 101% premium to its peers’ median range of 3.48 times.

The P/E ratio of Laurus Labs Ltd is 147.17 times as on 14-Feb-2025, a 296% premium to its peers’ median range of 37.17 times.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Laurus Labs Ltd and enter the required number of quantities and click on buy to purchase the shares of Laurus Labs Ltd.

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

The promoter of Laurus Labs Ltd is M/s. NSN Holdings (Represented by its Managing Partner, Dr. Satyanarayana Chava). M/s. NSN Holdings (Represented by its Managing Partner, Dr. Satyanarayana Chava) owns 23.02 per cent of the total equity. The chairman of the company is Ravindranath Kancherla ..

The promoters of Laurus Labs Ltd have pledged 0.74% of the total equity as on Dec-24.

Some of the close peers are:

Company Market Cap(₹ Cr)
37,287
27,803
27,702
24,500
Laurus Labs Ltd. Ratios
Return on equity(%)
4.86
Operating margin(%)
8.61
Net Margin(%)
3.69
Dividend yield(%)
0.15

Yes, TTM profit after tax of Laurus Labs Ltd was ₹200 Cr.